Pulmonx (LUNG) Non Operating Interest Expenses (2019 - 2025)

Pulmonx (LUNG) has reported Non Operating Interest Expenses for 7 consecutive years, with $805000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Non Operating Interest Expenses fell 9.65% year-over-year to $805000.0 in Q3 2025; TTM through Sep 2025 was $3.2 million, a 9.61% decrease from a year earlier, with the FY2024 full-year figure at $3.5 million, up 8.51% from the prior year.
• Non Operating Interest Expenses was $805000.0 for Q3 2025 at Pulmonx, up from $799000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $905000.0 in Q4 2023 and troughed at $198000.0 in Q1 2022.
• A 5-year average of $580000.0 and a median of $781000.0 in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 81.23% in 2021 and jumped 287.44% in 2023, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $199000.0 in 2021, then surged by 80.4% to $359000.0 in 2022, then jumped by 152.09% to $905000.0 in 2023, then fell by 6.96% to $842000.0 in 2024, then fell by 4.39% to $805000.0 in 2025.
• The last three Non Operating Interest Expenses figures came in at $805000.0 (Q3 2025), $799000.0 (Q2 2025), and $781000.0 (Q1 2025), per Business Quant data.